Lipocine Inc.
Filed with the SEC on · accession 0001493152-26-047693
LPCN filed a 8-K (current report) with the SEC on Oct 20, 2026. Lipocine Inc. filed an 8-K to disclose that it has updated its corporate investor presentation, which is filed as Exhibit 99.1. The stock moved +5.9% by the first close after the filing.
Lipocine Inc. filed an 8-K to disclose that it has updated its corporate investor presentation, which is filed as Exhibit 99.1. No operational, financial, or corporate governance changes were announced.
Close before
$1.53
Oct 19, 2026
First close after
+5.88%
$1.62
5 trading days
-5.23%
$1.45
Since filing
+2.61%
$1.57
✦ Ask GOAX AI about this filing — what it means for LPCN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LPCN?
Click hereLPCN filed a 8-K (SEC filing). Lipocine Inc. filed an 8-K to disclose that it has updated its corporate investor presentation, which is filed as Exhibit 99.1. No operational, financial, or corporate governance changes were announced.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
LPCN closed at $1.53 before the filing and $1.62 on Oct 20, 2026 (+5.88%). Five trading days later: $1.45 (-5.23%).
Get alerts when LPCN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days